The pathway to secondary prevention of Alzheimer's disease

Authors

Eric McDade, Washington University School of Medicine in St. Louis
Martin M Bednar, Takeda Pharmaceuticals International Co., Americas, Inc.
H Robert Brashear, Janssen Research and Development
David S Miller, Signant Health
Paul Maruff, Cogstate Ltd
Christopher Randolph, Loyola University Chicago
Zahinoor Ismail, University of Calgary
Maria C Carrillo, Alzheimer's Association
Christopher J Weber, Alzheimer's Association
Lisa J Bain, Independent Science Writer
Ann Marie Hake, Indiana University - Purdue University, Indianapolis

Journal

Alzheimer’s & Dementia: Translational Research & Clinical Interventions

Publication Date

1-1-2020

Volume

6

Issue

1

First Page

e12069

Document Type

Open Access Publication

DOI

10.1002/trc2.12069

Rights and Permissions

McDade E, Bednar MM, Brashear HR,et al. The pathway to secondary prevention of Alzheimer’sdisease. Alzheimer’s Dement. 2020;6:e12069.https://doi.org/10.1002/trc2.12069 This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. © 2020 The Authors. Alzheimer’s & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals, Inc. on behalf of Alzheimer’s Association.

Recommended Citation

McDade, Eric; Bednar, Martin M; Brashear, H Robert; Miller, David S; Maruff, Paul; Randolph, Christopher; Ismail, Zahinoor; Carrillo, Maria C; Weber, Christopher J; Bain, Lisa J; and Hake, Ann Marie, "The pathway to secondary prevention of Alzheimer's disease." Alzheimer’s & Dementia: Translational Research & Clinical Interventions. 6, 1. e12069 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9595